The healthcare industry is expected to grow significantly in 2022, thanks to strong demand amid rising chronic diseases, an aging population, and digital integration in healthcare systems. Furthermore, an increase in U.S. healthcare spending should fuel the industry’s growth. Given the bright growth prospects, we think the stocks of fundamentally sound healthcare companies Abbott (ABT), Quidel (QDEL), Medtronic (MDT), Fresenius (FMS), and Smith & Nephew (SNN), which are trading near their 52-week price lows, are ideal investments now. So, read on.